| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UltraRapid Communications |
From the Departments of Obstetrics & Gynecology (R.A.A.) and Surgery (S.K.B.) and Divisions of Cardiovascular Diseases (Y.S., L.A.W., L.L., K.T.W.), Connective Tissue Diseases (K.J.W., P.A.H., A.E.P.), and Endocrinology (I.C.G.), Department of Medicine, University of Tennessee Health Science Center, Memphis, Tenn.
Correspondence to Karl T. Weber, MD, University of Tennessee Health Science Center, Division of Cardiovascular Diseases, Room 353 Dobbs Research Institute, 951 Court Ave, Memphis, TN 38163. E-mail ktweber{at}utmem.edu
| Abstract |
|---|
|
|
|---|
Key Words: aldosterone peripheral blood mononuclear cells hydrogen peroxide production cytosolic free Mg2+ and Ca2+ transcriptome
| Introduction |
|---|
|
|
|---|
A role for angiotensin (Ang) II and aldosterone (ALDO) in the pathogenesis of the systemic illness that accompanies CHF is an area of ongoing research. A rodent model has been used to address the consequences of chronic inappropriate (relative to dietary Na+ intake) elevations in plasma ALDO comparable to those seen in human CHF. Treatment with ALDO and 1% dietary NaCl (ALDOST) rapidly suppresses plasma renin and Ang II.28,29 After 4 weeks of treatment with ALDOST, coronary vascular lesions are first seen in the normotensive, nonhypertrophied right atrium and ventricle and left atrium as well as in the hypertensive, hypertrophied left ventricle.30 Chronic mineralocorticoid excess, in combination with dietary salt excess and independent of blood pressure, is also known to adversely affect the structure of intramural arteries of systemic organs, including kidneys, pancreas, and mesentery, which can be prevented by ALDO-receptor antagonist.3140
Commonly featured in coronary vascular lesions are inflammatory cells and myofibroblasts.28,30,41 In the monocytes/macrophages and lymphocytes that invade intramural coronary arteries, Sun et al42 found an induction of oxidative/nitrosative stress and activation of a redox-sensitive nuclear transcription factor-
B (NF-
B), together with upregulated mRNA expression of a proinflammatory mediator cascade that NF-
B regulates. Cotreatment with either spironolactone (Spi), an ALDO receptor antagonist, or an antioxidant prevented these molecular events. Eplerenone, another ALDO receptor antagonist, is also cardioprotective in this model.43 This proinflammatory/fibrogenic cardiac phenotype is not seen with ALDO plus a 0.4% NaCl diet or with a 1% NaCl diet alone.44 Moreover, cardioprotective effects of ALDO receptor antagonism during ALDOST are seen with either nondepressor or depressor doses of Spi.45 The importance of ALDOST (vis-a-vis hemodynamic factors) in eliciting this phenotype has been demonstrated in multiple studies reported over the last decade.28,38,39,41,42,4548 Nevertheless, there are many gaps in our knowledge regarding the role of ALDO and Na+ in the pathogenesis of coronary vascular remodeling, including questions of whether immune cells are activated before tissue invasion and what accounts for the induction of oxidative/nitrosative stress in these cells. Given that Spi abrogates these immune cell responses, as recently reported,42 whether its mechanism of action is immodulatory remains to be determined.
An Na+-dependent reduction in cytosolic free Mg2+ ([Mg2+]i) accompanies ALDO receptor-ligand binding in cultured human lymphocytes.49,50 Herein we hypothesized ALDOST leads to a reduction in PBMC [Mg2+]i, the biologically active component of this important intracellular divalent cation, which, in turn, contributes to intracellular Ca2+ loading, the induction of oxidative/nitrosative stress, and immune cell activation before the appearance of the proinflammatory coronary vascular phenotype. We additionally hypothesized that Spi prevents these responses. Accordingly, blood was harvested weekly from uninephrectomized rats receiving ALDOST or ALDOST plus Spi for 4 weeks. We monitored PBMC [Mg2+]i and [Ca2+]i and several indices of oxidative/nitrosative stress, which included hydrogen peroxide (H2O2) generation by PBMCs, differential expression of PBMC genes, including those related to oxidative/nitrosative stress and antioxidant defenses, and circulating B and T lymphocyte responses. At week 4, we examined coronal sections of right and left ventricles for the presence of 3-nitrotyrosine in inflammatory cells that invaded the coronary vasculature. Age- and gender-matched unoperated/untreated and uninephrectomized rats receiving a 1% NaCl diet served as control groups.
| Materials and Methods |
|---|
|
|
|---|
Plasma and Cardiac Tissue Mg2+ Concentrations
Plasma was diluted 1:20 with 0.5% lanthanum chloride, and Mg2+ concentration was quantified in 100 µL specimens using a Varian model 220 FS double-beam fast sequential atomic absorption spectrophotometer (Varian Techtron) using a modification of the method of Bhattacharya.51 Plasma Mg2+ levels are expressed in milligrams per deciliter.
Microdetermination for Mg2+ concentration in ventricular myocardium was carried out in 12- to 15-mg demoisturized, defatted specimens after complete digestion in 0.75 mol/L Ultrex quality nitric acid (J.T. Baker Chemical Co) at 68°C for 15 hours.52 This procedure has been shown to extract >99% of Mg2+ from dry, defatted tissue. Tissue Mg2+ levels are expressed in nEq/mg of fat-free dry tissue.
Isolation of PBMCs
Heparinized whole blood (5 to 8 mL) was diluted to 10 mL with PBS (pH 7.4), layered on top of 5 mL Histopaque 1083, and centrifuged for 30 minutes at 400g. PBMCs were aspirated, washed twice, suspended in PBS, and counted with a hemocytometer.
Quantitation of Total Mg2+ and Ca2+ Concentration in PBMCs
Isolated PBMCs were washed three times with 140 mmol/L choline chloride. The PBMCs were then lysed with 2 mL deionized water and subjected to three cycles of alternate freezing at -70°C and thawing. An aliquot of 1.9 mL of isolated PBMC suspension containing 1 to 5 mg/mL protein was digested with 0.4 mL of 0.75 mol/L Ultrex quality nitric acid (J.T. Baker) for 24 hours at 68°C. The acid-extracted suspension was centrifuged, 1 mL of supernatant was diluted with 3 mL 0.5% LaCl3 solution, and the diluent was used to quantitate PBMC Mg2+ and Ca2+ levels by atomic absorption spectroscopy, as described elsewhere.52,53 The protein level in the PBMC suspension was assayed as previously described,54 and total Mg2+ and Ca2+ concentrations were expressed in micrograms per milligram of protein.
Cytosolic Free [Mg2+]i and [Ca2+]i in PBMCs
Separate PBMC aliquots (1x106 cells) were loaded with the cell-permeant fluorescent probes mag-fura-2 acetoxymethyl ester and fura-2 acetoxymethyl ester (Molecular Probes) for the radiometric measurement of [Mg2+]i and [Ca2+]i, respectively, using a Perkin-Elmer LS-50B spectrofluorometer according to the method of Delva et al.50 After loading cells with mag-fura-2 and washing them, cells were suspended in a buffer containing Mg2+ for spectrofluorometric measurement. Some mag-fura-2 leaks back out of the cells and is available to react with extracellular Mg2+. EDTA and EGTA are added to the suspension to chelate this extracellular Mg2+ so that only intracellular Mg2+/mag-fura-2 fluorescence (or resting cytosolic ionized Mg2+) is measured. As a result of this chelation of extracellular Mg2+, there is a small decrease in fluorescence. It is this latter value, after the addition of EDTA and EGTA, that represents true cytosolic Mg2+ and is reported herein. The measurement of Ca2+ reported herein likewise is made after addition of the chelator EGTA so that only true free cytosolic Ca2+ is measured. Specific details can be found elsewhere,55 and an online data supplement is available at http://www.circresaha.org.
Hydrogen Peroxide Generation by PBMCs
For the measurement of hydrogen peroxide (H2O2) production, 100-µL aliquots of whole blood obtained serially from the same animals by cardiac punction were incubated with 2,7-dichlorofluorescein diacetate (25 µmol/L) for 45 minutes at 37°C. After lysing erythrocytes with FACS lysing solution (Becton Dickinson), leukocytes were washed twice and suspended in PBS (pH 7.4). Lymphocyte and monocyte H2O2 production was measured using a FACS Caliber flow cytometer (Becton Dickinson) according to the method of Bass et al.56 For specific details, see the online data supplement.
PBMC Transcriptome
Total RNA was isolated from purified PBMC using a trireagent (Invitrogen). The gene expression analysis was conducted as previously described55,57 using the Affymetrix rat genome U34A chip (Affymetrix), probing
7000 known genes and 1000 expressed sequence tags. A total of six unoperated/untreated controls, six ALDOST obtained at each time point, and six ALDOST+Spi obtained at each time point went into the characterization of transcriptomes. Each sample analyzed on expression array chips consisted of pooled RNA from three animals. We compared transcriptomes from untreated controls with samples obtained at weeks 1 through 4 of ALDOST to produce a list of genes affected by the treatment. The experiment was repeated, and only genes that showed differential expression (
2-fold) in response to treatment in both of these independent experiments are reported as differentially expressed genes.
Multicolor Flow Cytometric Analysis of Lymphocyte Activation
Heparinized blood was obtained by cardiac puncture, and PBMCs were isolated by density-gradient centrifugation over Histopaque 1077 (Sigma). PBMCs were counted, washed twice, and resuspended in Dulbeccos PBS (Invitrogen Corporation) supplemented with 2% FCS. For cell-surface labeling, PBMCs (9x105/sample) were incubated with a cocktail of FITC-labeled, PE-labeled, PercP-labeled, and APC-labeled antibodies at 4°C for 20 minutes, washed, and resuspended in PBS-2% FCS. The mouse anti-rat mAbs used for flow cytometry in this study were as follows: FITC-conjugated G4.18 (anti-CD3) and OX-33 (anti-CD45RA), PE-conjugated OX-18 (anti-major histocompatibility [MHC] class I/RT1-A), PercP-conjugated OX-8 (anti-CD8) and OX-6 (anti-MHC class II/RT1-B), and APC-conjugated 1F4 (anti-CD3) and OX-35 (anti-CD4) (all from BD Biosciences, San Jose, Calif). Parallel samples of cells were also incubated with Ig isotypic controls (BD Biosciences). Optimal antibody dilutions were determined in preliminary experiments. All samples were immediately analyzed on a FACS Caliber flow cytometer (Becton Dickinson). Fluorescence data from at least 30 000 cells (from a lymphocyte gate) were collected for each sample. Offline analyses of raw data were performed using WinMDI software (J. Trotter, Scripps Institute).
3-Nitrotyrosine in Invading Inflammatory Cells
Expression of oxidative/nitrosative stress was studied by immunohistochemical localization of 3-nitrotyrosine. Lymphocytes and macrophages were detected by immunohistochemical assessment using CD4 and ED-1, respectively. Coronal cryostat sections (6 µm) were prepared, air-dried, fixed in 10% buffered formalin for 5 minutes, and washed in PBS for 10 minutes. Sections were then incubated with primary antibody against 3-nitrotyroxine at a dilution of 1:100 (Upstate Biotech, Waltham, Mass) or CD4 at a dilution of 1:50 (Becton Dickinson) or ED-1 at a dilution of 1:140 (Harlan Bioproducts) in PBS containing 1% BSA for 60 minutes. Sections were then washed in PBS for 10 minutes and incubated with IgG peroxidaseconjugated secondary antibody (Sigma) with a dilution of 1:150, washed in PBS for 10 minutes, incubated with 0.5 mg/mL diaminobenzidine tetrahydrochloride 2-hydrate plus 0.05% H2O2 for 10 minutes, and rewashed in PBS. Negative control sections were incubated with secondary antibody alone, stained with hematoxylin, dehydrated, mounted, and examined by light microscopy.
Statistics
Results for plasma and cardiac tissue [Mg2+], total PBMC Mg2+ and Ca2+, PBMC [Mg2+]i and [Ca2+]i, and H2O2 production by PBMCs are expressed as mean±SEM. Data were analyzed by ANOVA, and significant differences between groups were determined using the Students Newman-Keuls multiple-comparisons test and considered statistically significant when P<0.05.
An expanded Materials and Methods section can be found in the online data supplement, available at http://www.circresaha.org.
| Results |
|---|
|
|
|---|
|
Systolic blood pressure at week 1 ALDOST was no different from unoperated/untreated and uninephrectomized/salt-treated control groups but rose gradually thereafter and was significantly greater (P<0.05) than controls at weeks 3 and 4 (Table). Cotreatment with Spi prevented the gradual rise in blood pressure, with animals remaining normotensive throughout the 4-week period of observation (Table).
|
Plasma and Cardiac Tissue Mg2+ Concentrations
The concentration of plasma Mg2+ at 4 weeks of ALDOST treatment (1.51±0.10 mg/dL) was no different from unoperated/untreated or uninephrectomized/salt-treated controls (1.40±0.06 and 1.45±0.15 mg/dL, respectively) and was not altered by cotreatment with Spi (1.74±0.17 mg/dL). The concentration of Mg2+ in cardiac tissue in unoperated/untreated and uninephrectomized/salt-treated controls was 79.91±9.61 and 80.17±9.32 nEq/mg FFDT and remained unchanged at 4 weeks ALDOST (75.77±6.34 nEq/mg FFDT).
Total Intracellular Mg2+ and Ca2+ in PBMCs
Total Mg2+ in PBMCs harvested from untreated controls was 1.45±0.05 µg/mg protein. At weeks 1 through 4 of ALDOST treatment, this value was found to be increased to 1.63±0.13, 1.85±0.07, 1.68±0.03, and 1.71±0.11 µg/mg protein, respectively.
The total concentration of Ca2+ in PBMCs obtained from controls was 0.60±0.05 µg/mg protein. PBMC total Ca2+ was increased in response at 1 to 4 weeks of ALDOST treatment to 0.87±0.03, 0.77±0.08, 0.83±0.23, and 1.14±0.11 µg/mg protein, respectively.
Cytosolic Free [Mg2+]i and [Ca2+]i in PBMCs
No difference in PBMC count was observed between controls and ALDOST with or without Spi cotreatment at any weekly time point (data not shown). Compared with controls and as shown in the left panel of Figure 2, PBMC [Mg2+]i was significantly (P<0.05) reduced at week 1 of ALDOST. At week 2, ionized [Mg2+]i levels were again normal and no different from unoperated/untreated or uninephrectomized/salt-treated controls. Thereafter, [Mg2+]i was again reduced (P<0.05) at weeks 3 and 4 of ALDOST. Spi cotreatment did not alter these sequential changes in [Mg2+]i observed with 1 to 3 weeks of ALDOST, but [Mg2+]i was at control levels at week 4 (Figure 2, left).
|
At week 1 of ALDOST, PBMC [Ca2+]i was unchanged from controls but rose progressively thereafter and was greater than both control groups at weeks 2, 3, and 4 (Figure 2, right). Spi cotreatment abrogated intracellular Ca2+ loading during weeks 2 through 4 of ALDOST (Figure 2, right).
Hydrogen Peroxide Generation by PBMCs
At week 1 of ALDOST, H2O2 generation was no different from baseline levels before uninephrectomy and to initiating ALDOST (Figure 3). At week 2 of ALDOST, monocytes (left) and lymphocytes (right) demonstrated increased H2O2 production compared with baseline and week 1 values, and this was sustained at weeks 3 and 4 (Figure 3). Spi cotreatment abrogated increased H2O2 generation by both monocytes and lymphocytes at weeks 2, 3, and 4 of ALDOST treatment (Figure 3).
|
PBMC Transcriptome
For the analysis of PBMC-expressed genes, ie, their transcriptome, three pooled blood samples were obtained from nine controls, whereas those harvested weekly from rats receiving either ALDOST or cotreatment with Spi were harvested from 24 rats per treatment group with six rats at each time point per group. Gene chip array analysis was interrogated and compared for the differential (
2-fold) expression (either upregulated or downregulated) of genes related to shifts in intracellular monovalent and divalent cations, Na+, Mg2+, and Ca2+, the presence of oxidative/nitrosative stress, and PBMC activation and phenotype.
Relevant to the decline in PBMC [Mg2+]i seen during week 1 of the preclinical stage of ALDOST, which was presumably accompanied by Na+ loading (not measured), we found upregulated gene expression of an ATPase inhibitor protein (Figure 4, top left) and an Na+-dependent transporter (Figure 4, bottom left), which was sustained over 4 weeks. Spi cotreatment attenuated these responses. Other upregulated PBMC genes seen during this time frame with ALDOST (not shown) included somatostatin receptor and Na+-dependent serotonin transporter, whereas the
1 isoform of Na+/K+-ATPase was downregulated. Spi cotreatment served to attenuate these responses at all time points. We did not find specific genes that only became markedly (>2-fold) upregulated or downregulated at weeks 3 or 4 of ALDOST treatment or that responded in a like manner to Spi cotreatment at these time points.
|
Intracellular Ca2+ loading, initially of organelles, and subsequently free ionized cytosolic levels appeared during the preclinical stage of ALDOST and were associated with upregulated expression of an ATP-dependent Ca2+ pump (Figure 4, top right) and calmodulin kinase, a Ca2+-dependent protein kinase Cassociated kinase (Figure 4, bottom right). Cotreatment with Spi attenuated these responses. Other Ca2+-related genes that were upregulated during this time period of ALDOST (not shown) included calgranulin A, a Ca2+-binding chemokine, and proteins involved in intracellular Ca2+ binding, such as calgranulin B, lipocortin I, and a Ca2+-binding protein. A downregulation in gene expression (not shown) was seen for Ca2+-inhibitable adenyl cyclase, whereas FAK-2, a Ca2+-dependent tyrosine kinase, was unchanged from controls. Spi attenuated the response in Ca2+ binding protein but did not alter these other responses at any time point. We did not find specific genes that were first markedly upregulated or downregulated at weeks 3 or 4 of ALDOST or that were similarly altered by Spi cotreatment.
The presence of oxidative/nitrosative stress in PBMCs throughout 4 weeks of ALDOST treatment was evidenced by responses in their transcriptome. This included an early, upregulated expression of oxidative stressinducible tyrosine phosphatase (not shown) and such antioxidant defenses as Mn2+-superoxide dismutase and L-cysteine oxireductase (Figure 5, top and bottom). Inducible NO synthase was also upregulated (not shown) and is integral to NO formation that regulates the mitochondrial electron transport chain, a major source of reactive oxygen species. Glutathione peroxidase and reductase, catalase, and NADPH oxireductase were not altered. During weeks 2 through 4 of ALDOST and accompanying the increased H2O2 production by PBMCs, we found an activation and iteration in their phenotype. Evidence of early PBMC activation included upregulated expression of intracellular adhesion molecule (ICAM)-1 and integrin
1 (Figure 6, top and bottom), cell adhesion regulator, CC chemokine receptor protein, chemokine receptor CCR2, CXC chemokine receptor, interleukin (IL)-1ß and its receptor type 2 and accessory protein, and interferon-
inducible GTP cyclohydrolase. Spi attenuated these responses. An iteration in PBMC phenotype was suggested by a downregulation in MHC class I molecule together with upregulated expression of MHC class II Aß (Figure 6, top right), IgE binding protein, IgG2b rearranged gene, and IgA constant region (not shown). Autoreactivity was evidenced by upregulated gene expression of antibodies to acetylcholine receptors and nerve growth factor and a downregulation to the expression of RT-6.2 (Figure 6, bottom right), each of which was attenuated by Spi cotreatment.
|
|
Lymphocyte Activation
Our transcriptome data suggested ALDOST treatment is accompanied by B-cell activation (eg, increased immunoglobulin gene transcription). At week 4, we determined the B/T cell ratio in control, ALDOST, and Spi cotreated rats by flow cytometry (Figure 7) and found a relative expansion of the B lymphocyte subset in ALDOST rats compared with UN controls and that was attenuated by Spi. Moreover, MHC class IIexpressing lymphocytes were increased in ALDOST rats at week 4, consistent with the upregulation of MHC II genes. The increase in MHC class IIpositive cells is also in keeping with the immune activation induced by ALDOST. Indeed, by multicolor flow cytometry, we confirmed that the B-cell subset is the major class IIexpressing population of lymphocytes. Within the CD3+ T-cell population, we did not detect differences in the CD4/CD8 ratio among the various treatment groups (data not shown).
|
3-Nitrotyrosine in Immune Cells Invading the Coronary Vasculature
As reported previously,41,42 the proinflammatory coronary vascular phenotype first appears at week 4 of ALDOST treatment. Peroxynitrite (OONO-) is a potent reactive nitrogen species formed by the reaction of NO and superoxide. Its short half-life makes detection of OONO- difficult. However, its reaction with stable tyrosine residues forms a stable 3-nitrotyrosine derivative and serves as a marker of nitrosative stress. Immunohistochemical evidence of 3-nitrotyrosine was found in inflammatory cells, including CD4+ lymphocytes, that invaded the coronary vasculature of the right and left heart at week 4 of ALDOST (Figures 8A and 8C). ED-1positive macrophages were also found to have 3-nitrotyrosine labeling (not shown). Cotreatment with Spi prevented the appearance of 3-nitrotyrosine labeling in cells that invaded intramural coronary arteries (Figures 8B) and attenuated the number of inflammatory cells seen at these sites.
|
| Discussion |
|---|
|
|
|---|
Beginning with the preclinical stage of ALDOST, we found a reduction in PBMC [Mg2+]i that was significantly lower than levels found in PBMCs obtained from either of our two control groups or historical controls reported by others.58 Furthermore, the fall in this biologically active component of intracellular Mg2+ seen with ALDOST is in keeping with significantly reduced human lymphocyte [Mg2+]i found in patients with primary aldosteronism.50 The mechanism responsible for the reduction in [Mg2+]i is unknown. It could involve an efflux out of the cell, a shift within the cells compartments, or both. Delva et al50 reported a Na+-dependent, ALDO-mediated reduction in [Mg2+]i in cultured human lymphocytes that involved transcription and protein synthesis; thereby, a putative Na+/Mg2+ exchange site59 was implicated. In chicken erythrocytes, Mg2+ efflux is dependent on extracellular Na+ with a stoichiometry of 1 Mg2+ coupled with the influx of 2 Na+ via a Na+/Mg2+ exchanger.60 Cytosolic free [Mg2+]i represents 0.5% to 5% of total cellular Mg2+, and the remainder is bound to ATP and other phosphometabolites sequestered within such organelles as mitochondria and endoplasmic reticulum.61 At week 2 of ALDOST treatment, PBMC [Mg2+]i was similar to that seen in our controls. This might reflect homeostatic regulation from these organelles, although the appearance of a new PBMC population cannot be ruled out. A decline in PBMC [Mg2+]i was again seen at weeks 3 and 4 of ALDOST. Other explanations accounting for the reduction in [Mg2+]i need to be considered. PBMC total Mg2+ concentration was increased during weeks 1 through 4 of ALDOST and likely includes the activation of protein kinase C to promote Mg2+ entry and compartmentalization with the opening of mitochondrial permeability transition pores induced by oxidative/nitrosative stress and Ca2+ loading.6264 A reduction in organella Mg2+ stores therefore cannot be implicated in the fall of [Mg2+]i. Given that cytosolic free [Mg2+]i represents such a small fraction of total Mg2+, it is not likely that the observed increase in total Mg2+ could be attributed to this source. We did not find a reduction in plasma [Mg2+] or a decline in cardiac tissue [Mg2+] with 4 weeks of ALDOST, even though urinary Mg2+ excretion (not measured herein) can be enhanced by ALDO.65 We cannot implicate dietary Mg2+ deficiency, given that the Mg2+ content of our standard chow (20 to 40 mmol/kg) is in keeping with daily requirements and far greater than that (<2 mmol/kg) needed to induce dietary Mg2+ deficiency.66,67 Future studies are planned to address responsible mechanisms.
Mg2+ is involved in >300 enzymatic reactions, including Mg2+-dependent Na+/K+-ATPase.59,61 A reduction in the activity of this exchanger leads to a rise in intracellular Na+ followed by the stoichiometric exchange of 3 Na+ for 1 Ca2+ via a Na+/Ca2+ exchanger.68,69 At week 1 of ALDOST treatment, analysis of PBMC transcriptome revealed upregulated expression of an ATPase inhibitor protein and Na+-dependent transporter, together with a downregulation in
1 isoform of Na+/K+-ATPase and upregulation in ATP-dependent Ca2+ pump, each of which persisted during subsequent weeks of ALDOST treatment. Spi attenuated these responses. Total intracellular Ca2+ was increased throughout the 4-week period of ALDOST and is likely responsible for the early and persistent induction of oxidative/nitrosative stress. PBMC [Ca2+]i rose at weeks 2 through 4 of ALDOST treatment, in keeping with the saturation of organella stores during week 1. ALDO and extracellular Na+ are each known to upregulate Ca2+ uptake in various cells, including lymphocytes.70,71 Furthermore, ALDO reversibly downregulates the activity of a Na+/Ca2+ exchanger, which would inhibit net Ca2+ efflux from PBMCs.72,73 Collectively, these responses would account for intracellular Ca2+ loading, which we observed for both cytosolic free [Ca2+]i and total Ca2+ concentration of PBMCs. In both humans and experimental animals, chronic mineralocorticoid excess, derived from either endogenous or exogenous sources and inappropriate for dietary Na+, is associated with a rise in platelet [Ca2+]i and release of endogenous, circulating ouabain, a Na+/K+-ATPase inhibitor, which normalized after surgical ablation.7478 Na+-Ca2+ exchange is dependent on cell Na+ and is competitively inhibited by Mg2+.79 A 4-g NaCl diet in a black population with salt-sensitive hypertension is accompanied by increases in erythrocyte Ca2+ and Na+ concentrations and Ca2+-ATPase activity, whereas [Mg2+]i and Na+/K+-ATPase activity are each reduced.80 Spi cotreatment in our rodent model of ALDOST prevented the rise in [Ca2+]i that appeared at weeks 2 through 4 of ALDOST treatment, suggesting that it altered Na+ delivery to and Na+/Ca2+ exchange in PBMCs.81 The fall in [Mg2+]i, which was not prevented by Spi, does not therefore seem to be an absolute prerequisite to PBMC Ca2+ loading. However, a reduction in [Mg2+]i, a physiological antagonist to Ca2+ entry, would indirectly elevate [Ca2+]i.81 ALDO also increases the density of Ca2+ current and Ca2+ channel expression, responses blunted by Spi.71 Nifedipine, a dihydropteridine Ca2+ entry blocker, prevents renovascular lesions that accompany chronic mineralocorticoid excess.82 Thus, our findings implicate Na+-dependent intracellular Ca2+ loading as integral to other events that appeared in PBMCs during ALDOST. Increased [Ca2+]i is an intracellular messenger integral to lymphocyte activation that appears in response to antigen-binding and antigen-presenting cells.83 It has been reported to play a major regulatory role in the generation of reactive oxygen species in chemotactic factorstimulated neutrophils.81
Concordant with the rise in intracellular Ca2+ was the induction of oxidative/nitrosative stress in PBMCs, as indicated by several lines of evidence. PBMC transcriptome at 1 to 4 weeks of ALDOST treatment revealed overexpression of oxidative stressinducible tyrosine phosphatase and upregulation of enzymes associated with antioxidant defense systems, such as Mn2+-superoxide dismutase (SOD), L-cysteine, and NADPH oxireductases, and inducible NO synthase. In monocytes and lymphocytes obtained from rats receiving ALDOST at 2 to 4 weeks, we found evidence of increased H2O2 production, suggesting antioxidant defenses in these cells were no longer able to neutralize this stress, as presumably had been the case at week 1. Persistent oxidative/nitrosative stress may have contributed to the appearance of the systemic illness and catabolic state seen in these rats at weeks 3 through 4 of ALDOST, which featured lethargy, anorexia, and a failure to gain weight. In preventing oxidative/nitrosative stress, Spi cotreatment prevented this clinical response. At week 4 of ALDOST treatment, we found immunohistochemical localization of 3-nitrotyrosine in inflammatory cells that invaded intramural coronary arteries. Sun et al42 have previously reported the presence of oxidative/nitrosative stress in these immune cells that first invade the coronary circulation at 4 weeks of ALDOST treatment. This included activation of gp91phox, a membrane-bound NADPH oxidase subunit, and the RelA subunit of a redox-sensitive NF-
B, together with a proinflammatory mediator cascade it regulates. This cascade included upregulated mRNA expression of ICAM-1, monocyte chemoattractant protein (MCP)-1, and tumor necrosis factor (TNF)-
. These cellular and molecular events were not seen when ALDOST was combined with either an antioxidant or Spi. Herein, we report the prevention of the rise in PBMC [Ca2+]i by Spi cotreatment, and this negated the induction of oxidative/nitrosative stress in these immune cells that invade the coronary vasculature.
A third finding of our study was the activation of PBMCs before the appearance of the proinflammatory coronary vascular phenotype seen at week 4 of ALDOST treatment. This occurred in the absence of myocardium-derived antigen, given that the heart in our rat model is intact and free of prior injury. This early immunostimulatory state included (1) B-cell activation with increased expression of immunoglobulins; (2) an expansion of the B-cell lymphocyte subset; (3) an increase in MHC class IIexpressing lymphocytes; (4) increased expression of ICAM-1, integrin
1, CC chemokine receptor protein and receptor CCR2, CXC chemokine receptor, IL-1ß, its receptor type 2, and accessory protein; and (5) inducible interferon-
. There was also evidence to implicate autoreactivity with increased expression of antibodies to acetylcholine receptors and nerve growth factor and reduced RT-6.2. RT-6, an alloantigenic marker of mature resting T cells, is lost on activation. Cytotoxic T cells do not display RT-6 and are associated with autoimmunity.8487 RT-6 exists in at least two allelic forms, RT-6.1 and RT-6.2, where RT-6.2 consists of a nonglycosylated 25- and 28-kDa form.88 Circulating levels of CC chemokines, including MCP-1, macrophage inflammatory protein (MIP)-1
, and RANTES (Regulated on Activation Normally T Cell Expressed and Secreted), are increased particularly in patients with advanced, symptomatic failure at rest (NYHA class IV) irrespective of its etiologic origins.16 Monocytes and CD3+ lymphocytes (T lymphocytes) obtained from individuals with NYHA class III and IV failure have been studied in culture with respect to their release of CC chemokines.16 In response to stimulation of monocytes with LPS or CD3+ lymphocytes with anti-CD3/anti-CD28 monoclonal antibodies, increased release of MIP-1
and MCP-1 was observed for monocytes and increased release of RANTES by CD3+ lymphocytes (vis-a-vis healthy blood donor controls). The effect of serum from these patients on superoxide generation by cultured monocytes harvested from healthy blood donors was also examined.16 Spontaneous and provoked generation of superoxide was enhanced and to an extent related to serum MCP-1 levels, which could be inhibited by neutralizing antibodies to this CC chemokine. Serum levels of CXC chemokines, including IL-8, growth-regulated oncogene
, and epithelial neutrophil activating peptide-78, are also elevated in patients with heart failure and to an extent related to the severity of symptomatic heart failure.17 Furthermore, spontaneous and LPS-stimulated monocytes from these patients release elevated amounts of these CXC chemokines.17 Damås et al18 demonstrated upregulated PBMC gene expression (ribonuclease protection assay) for MIP-1
, MIP-1ß, IL-8, and their corresponding receptors, which include CCR1 and CCR5, CXC chemokine receptor 1, and CXC chemokine receptor 2 in patients with heart failure of diverse causality. Thus, in humans with symptomatic heart failure, where salt and water retention and elevated plasma levels of ALDO are expected, as well as in our rodent model of ALDOST, there is evidence of sustained monocyte and lymphocyte activation. Such "runaway inflammation" may contribute to the chronic "cytokine storm" seen with the CHF syndrome. An initial immunostimulatory state that begins during week 1 of ALDOST treatment, based on Na+-dependent, ALDO-induced activation of PBMCs, is sustained and begets an immunopathologic state with cardiac lesions at week 4. Dietary-induced Mg2+ deficiency and associated aldosteronism89,90 is accompanied by reduced Mg2+ and increased Na+ and Ca2+ in lymphocytes,91 evidence of oxidative/nitrosative stress in plasma, reduced antioxidant reserves in PBMCs, elevated PBMC proinflammatory cytokine production at week 1, and a delayed appearance in cardiac pathology seen at week 3,66,67 together with upregulated expression of stress proteins and glutathione transferase in neutrophils and thymocytes.92,93 The appearance of exaggerated immune cell responses seen with Mg2+ deficiency includes superoxide anion production and enhanced [Ca2+]i, which have been attributed to abnormal Ca2+ handling.94
We believe the antigen-independent activation of cellular immunity seen with ALDOST is related to H2O2 production and its role as second messenger. Reth95 has reviewed the evidence implicating H2O2 as second messenger capable of antigen mimicry. Redox-regulated proteins include transcription factors that can either prevent (p53) or stimulate (p50) their transcriptional activity. Other redox-regulated proteins, which we observed in our analysis of PBMC transcriptome, are the protein tyrosine phosphatases. They are rendered inactive by H2O2. In lymphocytes, H2O2 can be spontaneously generated from superoxide and protons in water or catalyzed by cytosolic SOD. Another source of superoxide is NADPH oxidase/reductase. In response to ALDOST, we found upregulated expression of both SOD and NADPH oxidase/reductase in PBMC transcriptome. Sun et al42 found immunohistochemical evidence that the gp91phox subunit of NADPH oxidase was activated in cells invading the intramural coronary vasculature. NADPH oxidase is pertinent to inducible oxidative/nitrosative stress in lymphocytes during signal transduction.96 Lymphocytes produce H2O2 on stimulation of their antigen receptor, whereas immunoglobulins (or antibodies) do not require a particular antigen binding site to incite H2O2 production.9799 Receptors can be activated in a ligand-independent manner when immune cells are treated with H2O2. B-cell activation leads to antibody production. In patients with heart failure of diverse origins, circulating antibodies to muscarinic M2-acetylcholine receptors (AchR) have been observed and correlated with the severity of their symptomatic status.100104 Specific immune responses may be involved in activated PBMCs targeting the intramural coronary vasculature and could explain why cardiac lesions of the right and left heart are not seen until week 4 of ALDOST treatment. Adoptive transfer studies have been planned to address the issues concerning an autoimmune response. However, the need for coronary endothelial cell activation in contributing to this response remains uncertain.
Findings of this study relate to the pathophysiology of chronic cardiac failure in humans, where an activation of the circulating RAAS is accompanied by a progressive systemic illness that features oxidative/nitrosative stress, lethargy, and a catabolic state with wasting. Herein, we found ALDOST in rodents to lead to an early activation of PBMCs before the appearance of lethargy, anorexia, failure to gain weight, and coronary lesions. The prospect of B-cell activation and autoreactivity in the absence of antigen presentation calls into question their potential for autoimmune-mediated injury that targets the intramural vasculature and leads to a progressive structural remodeling of involved vessels. Functional consequences of antibody interference with AchR seen with ALDOST may include a modulation of parasympathetic control of heart rate and conduction,105 reduced baroreceptor discharge,106 impaired vasodilator reserve to Ach,40,107 and nerve growth factor that maintains the integrity of sympathetic innervation.108 Our observations broaden the paradigm embraced by the concept of a neuroendocrine-immune interface.109,110
In summary, findings of this study have addressed several gaps in our knowledge. In aldosteronism, PBMCs are activated before invading the intramural coronary arterial circulation. Activation of these immune cells by intracellular Ca2+ loading leads to the induction of oxidative/nitrosative stress, including H2O2 production, which likely serves as second messenger to mimic antigen-receptor binding and lymphocyte activation. The clinical efficacy of ALDO receptor antagonism in the management of symptomatic heart failure,26,27 where aldosteronism is expected, may include its ability to modulate this neuroendocrine-immune interface.
| Acknowledgments |
|---|
This study was supported in part by NIH grants R01-DK62403, R24-RR-15373, and R21-DK-55263 (to I.C.G.), National Heart, Lung, and Blood Institute grants R01-HL67888 (to Y.S.), and R01-HL62229 (to K.T.W.) and grants from the UTHSC Center of Excellence in Connective Tissue Diseases (to Y.S. and K.T.W.).
| Footnotes |
|---|
| References |
|---|
|
|
|---|
. J Am Coll Cardiol. 1993; 22: 18971901.[Abstract]